4//SEC Filing
THOMPSON W LEIGH MD PHD 4
Accession 0001209191-04-027894
CIK 0000920465other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 10:00 PM ET
Size
35.8 KB
Accession
0001209191-04-027894
Insider Transaction Report
Form 4
THOMPSON W LEIGH MD PHD
Director
Transactions
- Award
Stock Option (right to buy)
2004-05-21+10,265→ 10,265 total(indirect: By Partnership)Exercise: $3.69Exp: 2010-01-28→ Common Stock (10,265 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-05-21−20,000→ 0 total(indirect: By Daughter)Exercise: $3.63Exp: 2006-05-21→ Common Stock (20,000 underlying) - Award
Stock Option (right to buy)
2004-05-21+3,796→ 3,796 total(indirect: By Partnership)Exercise: $0.34Exp: 2009-11-02→ Common Stock (3,796 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-05-21−10,265→ 0 total(indirect: By Partnership)Exercise: $3.69Exp: 2006-05-21→ Common Stock (10,265 underlying) - Award
Stock Option (right to buy)
2004-05-21+20,000→ 20,000 total(indirect: By Daughter)Exercise: $3.63Exp: 2008-12-03→ Common Stock (20,000 underlying) - Award
Stock Option (right to buy)
2004-05-21+38,939→ 38,939 total(indirect: By Partnership)Exercise: $0.48Exp: 2009-09-28→ Common Stock (38,939 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-05-21−3,796→ 0 total(indirect: By Partnership)Exercise: $0.34Exp: 2006-05-21→ Common Stock (3,796 underlying) - Award
Stock Option (right to buy)
2004-05-21+5,000→ 5,000 total(indirect: By Partnership)Exercise: $2.97Exp: 2013-05-12→ Common Stock (5,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-05-21−38,939→ 0 total(indirect: By Partnership)Exercise: $0.48Exp: 2006-05-21→ Common Stock (38,939 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-05-21−5,000→ 0 total(indirect: By Partnership)Exercise: $2.97Exp: 2006-05-21→ Common Stock (5,000 underlying)
Footnotes (6)
- [F1]Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 09/28/1999. Options were fully vested on 12/28/2000.
- [F2]Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 11/02/1999. Options were fully vested on 12/02/2000.
- [F3]Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 01/28/2000. Options were fully vested on 12/28/2000.
- [F4]Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was granted on 5/12/2003. On 5/21/04, 1,667 options were vested. Dr. Thompson ceased being a director of the Company on 5/21/04. Immediately prior to his cessation of service as a director the vesting period was accelerated so that all options were fully vested on 5/21/04.
- [F5]Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was granted on 9/18/2003. On 5/21/04, 1,111 options were vested. Dr. Thompson ceased being a director of the Company on 5/21/04. Immediately prior to his cessation of service as a director the vesting period was accelerated so that all options were fully vested on 5/21/04.
- [F6]Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 12/03/1998. Options were fully vested on 12/03/2000.
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001234367
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 10:00 PM ET
- Size
- 35.8 KB